HONG KONG, Sept. 23, 2021 /PRNewswire/ — On September 24, Broncus (02216.HK), a pioneer in the field of interventional pulmonology in China, was successfully listed on the main board of the Hong Kong Stock Exchange.
Broncus, founded in 2012, is a medical…
Why Is the Stock Falling?
November 3, 2026
